Clinical implications of measurable residual disease in AML: Review of current evidence.
Crit Rev Oncol Hematol
; 133: 142-148, 2019 Jan.
Article
in En
| MEDLINE
| ID: mdl-30661650
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
Type of study:
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adult
/
Humans
Language:
En
Journal:
Crit Rev Oncol Hematol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2019
Document type:
Article
Country of publication:
Netherlands